1. Greco, A, Marinelli, C, Fusconi, M, et al. Clinic manifestations in granulomatosis with polyangiitis. Int J Immunopathol Pharmacol. 2016;29(2):151-159.
Google Scholar | SAGE Journals | ISI2. Lutalo, PMK, D’Cruz, DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun. 2014;48-49:94-98.
Google Scholar3. Blackabey, V, Gan, RWC, Buglass, H, Kaul, V, Ward, VMM. Granulomatosis with polyangiitis causing subglottic stenosis—two cases and their management. AME Case Rep. 2018;2:17.
Google Scholar | Crossref | Medline4. Taylor, SC, Clayburgh, DR, Rosenbaum, JT, Schindler, JS. Progression and management of Wegener’s granulomatosis in the head and neck. Laryngoscope. 2012;122(8):1695-1700.
Google Scholar | Crossref | Medline5. Martinez Del Pero, M, Jayne, D, Chaudhry, A, Sivasothy, P, Jani, P. Long-term outcome of airway stenosis in granulomatosis with polyangiitis (Wegener granulomatosis): an observational study. JAMA Otolaryngol Head Neck Surg. 2014;140(11):1038-1044.
Google Scholar | Crossref | Medline6. Trimarchi, M, Sinico, RA, Teggi, R, Bussi, M, Specks, U, Meroni, PL. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev. 2013;12(4):501-505.
Google Scholar | Crossref | Medline7. Jordan, NP, Verma, H, Siddiqui, A, Morrison, GA, D’Cruz, DP. Morbidity and mortality associated with subglottic laryngotracheal stenosis in granulomatosis with polyangiitis (Wegener’s granulomatosis): a single-centre experience in the United Kingdom. J Laryngol Otol. 2014;128(9):831-837.
Google Scholar | Crossref | Medline8. Marroquín-Fabián, E, Ruiz, N, Mena-Zúñiga, J, Flores-Suárez, LF. Frequency, treatment, evolution, and factors associated with the presence of tracheobronchial stenoses in granulomatosis with polyangiitis: retrospective analysis of a case series from a single respiratory referral center. Semin Arthritis Rheum. 2019;48(4):714-719.
Google Scholar | Crossref | Medline9. Quinn, KA, Gelbard, A, Sibley, C, et al. Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis. Rheumatology (Oxford). 2019;58(12):2203-2211.
Google Scholar | Crossref | Medline10. Martinez Del Pero, M, Rasmussen, N, Chaudhry, A, Jani, P, Jayne, D. Structured clinical assessment of the ear, nose and throat in patients with granulomatosis with polyangiitis (Wegener’s). Eur Arch Otorhinolaryngol. 2013;270(1):345-354.
Google Scholar | Crossref | Medline11. Monach, PA . L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener’s). La Presse Médicale. 2013;42(4, pt 2):575-576.
Google Scholar | Crossref | Medline12. Langford, CA, Sneller, MC, Hallahan, CW, et al. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener’s granulomatosis. Arthritis Rheum. 1996;39(10):1754-1760.
Google Scholar | Crossref | Medline13. Gluth, MB, Shinners, PA, Kasperbauer, JL. Subglottic stenosis associated with Wegener’s granulomatosis. Laryngoscope. 2003;113(8):1304-1307.
Google Scholar | Crossref | Medline14. Miloslavsky, EM, Lu, N, Unizony, S, et al. Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener’s): distinct patient subsets. Arthritis Rheumatol. 2016;68(12):2945-2952.
Google Scholar | Crossref | Medline15. Stone, JH ; Wegener’s Granulomatosis Etanercept Trial Research Group . Limited versus severe Wegener’s granulomatosis: baseline data on patients in the Wegener’s granulomatosis etanercept trial. Arthritis Rheum. 2003;48(8):2299-2309.
Google Scholar | Crossref | Medline16. Gadkaree, SK, Pandian, V, Best, S, et al. Laryngotracheal stenosis: risk factors for tracheostomy dependence and dilation interval. Otolaryngol Head Neck Surg. 2017;156(2):321-328.
Google Scholar | SAGE Journals | ISI17. Malm, I-J, Mener, DJ, Kim, J, Seo, P, Kim, YJ. Otolaryngological progression of granulomatosis with polyangiitis after systemic treatment with rituximab. Otolaryngol Head Neck Surg. 2014;150(1):68-72.
Google Scholar | SAGE Journals | ISI18. Guardiani, E, Moghaddas, HS, Lesser, J, et al. Multilevel airway stenosis in patients with granulomatosis with polyangiitis (Wegener’s). Am J Otolaryngol. 2015;36(3):361-363.
Google Scholar | Crossref | Medline19. Terrier, B, Dechartres, A, Girard, C, et al. Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience. Rheumatology (Oxford). 2015;54(10):1852-1857.
Google Scholar | Crossref | Medline20. Girard, C, Charles, P, Terrier, B, et al. Tracheobronchial stenoses in granulomatosis with polyangiitis (Wegener’s): a report on 26 cases. Medicine (Baltimore). 2015;94(32):e1088.
Google Scholar | Crossref | Medline21. Gardner, GM. Posterior glottic stenosis and bilateral vocal fold immobility: diagnosis and treatment. Otolaryngol Clin North Am. 2000;33(4):855-878.
Google Scholar | Crossref | Medline | ISI22. Morcillo, A, Wins, R, Gómez-Caro, A, Paradela, M, Molins, L, Tarrazona, V. Single-staged laryngotracheal reconstruction for idiopathic tracheal stenosis. Ann Thorac Surg. 2013;95(2):433-439.
Google Scholar | Crossref | Medline23. Reinhold-Keller, E, Beuge, N, Latza, U, et al. An interdisciplinary approach to the care of patients with Wegener’s granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000;43(5):1021-1032.
Google Scholar | Crossref | Medline24. Stone, JH, Merkel, PA, Spiera, R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221-232.
Google Scholar | Crossref | Medline | ISI25. Henes, JC, Fritz, J, Koch, S, et al. Rituximab for treatment-resistant extensive Wegener’s granulomatosis—additive effects of a maintenance treatment with leflunomide. Clin Rheumatol. 2007;26(10):1711-1715.
Google Scholar | Crossref | Medline26. Luqmani, RA. State of the art in the treatment of systemic vasculitides. Front Immunol. 2014;5:471.
Google Scholar | Crossref | Medline27. Gause, A, Metzler, C, Reinhold-Keller, E, Gross, WL. Leflunomide therapy for autoimmune diseases. In: Sticherling, M, Christophers, E, eds. Treatment of Autoimmune Disorders. Springer; 2003:43-48.
Google Scholar | Crossref28. Hazlewood, GS, Metzler, C, Tomlinson, GA, et al. Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis. Joint Bone Spine. 2014;81(4):337-341.
Google Scholar | Crossref | Medline29. Grygiel-Górniak, B, Limphaibool, N, Perkowska, K, Puszczewicz, M. Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features. Postgrad Med. 2018;130(7):581-596.
Google Scholar | Crossref | Medline30. Comarmond, C, Cacoub, P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev. 2014;13(11):1121-1125.
Google Scholar | Crossref | Medline31. Calich, AL, Puéchal, X, Pugnet, G, et al. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener’s): results of a single-center cohort study on 66 patients. J Autoimmun. 2014;50:135-141.
Google Scholar | Crossref | Medline32. Gouveris, H, Karaiskaki, N, Koutsimpelas, D, Chongolwatana, C, Mann, W. Treatment for adult idiopathic and Wegener-associated subglottic stenosis. Eur Arch Otorhinolaryngol. 2013;270(3):989-993.
Google Scholar | Crossref | Medline33. Solans-Laqué, R, Bosch-Gil, J, Canela, M, Lorente, J, Pallisa, E, Vilardell-Tarrés, M. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener’s granulomatosis. Lupus. 2008;17(9):832-836.
Google Scholar | SAGE Journals | ISI34. Charlson, ME, Pompei, P, Ales, KL, MacKenzie, CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
Google Scholar | Crossref | Medline35. Belafsky, PC, Mouadeb, DA, Rees, CJ, et al. Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117(12):919-924.
Google Scholar | SAGE Journals | ISI36. van der Molen, T, Willemse, BWM, Schokker, S, ten Hacken, NHT, Postma, DS, Juniper, EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
Google Scholar | Crossref | Medline37. Hogikyan, ND, Sethuraman, G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice. 1999;13(4):557-569.
Google Scholar | Crossref | Medline | ISI38. Hseu, AF, Benninger, MS, Haffey, TM, Lorenz, R. Subglottic stenosis: a ten-year review of treatment outcomes. Laryngoscope. 2014;124(3):736-741.
Google Scholar | Crossref | Medline | ISI39. Amorim, LD, Cai, J. Modelling recurrent events: a tutorial for analysis in epidemiology. Int J Epidemiol. 2015;44(1):324-333.
Google Scholar | Crossref | Medline40. Kelly, PJ, Lim, LL-Y. Survival analysis for recurrent event data: an application to childhood infectious diseases. Stat Med. 2000;19(1):13-33.
Google Scholar | Crossref | Medline | ISI41. Metzler, C, Fink, C, Lamprecht, P, Gross, WL, Reinhold-Keller, E. Maintenance of remission with leflunomide in Wegener’s granulomatosis. Rheumatology (Oxford). 2004;43(3):315-320.
Google Scholar | Crossref | Medline42. Feinstein, AJ, Goel, A, Raghavan, G, et al. Endoscopic management of subglottic stenosis. JAMA Otolaryngol Head Neck Surg. 2017;143(5):500-505.
Google Scholar | Crossref | Medline43. Lavrysen, E, Hens, G, Delaere, P, Meulemans, J. Endoscopic treatment of idiopathic subglottic stenosis: a systematic review. Front Surg. 2020;6:75.
Google Scholar | Crossref | Medline44. Roediger, FC, Orloff, LA, Courey, MS. Adult subglottic stenosis: management with laser incisions and mitomycin-C. Laryngoscope. 2008;118(9):1542-1546.
Google Scholar | Crossref | Medline | ISI45. Shabani, S, Hoffman, MR, Brand, WT, Dailey, SH. Endoscopic management of idiopathic subglottic stenosis: factors affecting inter-dilation interval. Ann Otol Rhinol Laryngol. 2017;126(2):96-102.
Google Scholar | SAGE Journals | ISI46. Volgger, V, Mann, SL, Englhard, AS, Berghaus, A. An eleven-year review on treatment outcome after endoscope-based and open surgery for subglottic stenosis. In: Laryngo-rhino-otologie. Vol 97. Georg Thieme Verlag KG; 2018:10159.
Google Scholar47. Cataneo, DC, Ximenes, AMG, Cataneo, AJM. Mitomycin C in the endoscopic treatment of tracheal stenosis: a prospective cohort study. J Bras Pneumol. 2018;44(6):486-490.
Google Scholar | Crossref | Medline48. Dion, GR, Chapa, JSDL, Bettenhausen, W, Dominguez, LM, Simpson, CB. Differing progression to posterior glottic stenosis in autoimmune and idiopathic subglottic stenosis. Laryngoscope. Published online September 9, 2020. doi:10.1002/lary.29085
Google Scholar | Crossref49. Hoasjoe, DK, Franklin, SW, Aarstad, RF, Day, TA, Stucker, FJ. Posterior glottic stenosis mechanism and surgical management. Laryngoscope. 1997;107(5):675-679.